It's been a good year for PIMCO but an off year for many American Funds.
Large drugmakers are out of favor, but some good funds are banking on a rebound.
Investors seeking reserved emerging-markets exposure do have a pair of good options.
©2017 Morningstar Advisor. All right reserved.